Trial Profile
A phase I multiple-dose, double-blind study of RG-7203 in patients with schizophrenia
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Dec 2014
Price :
$35
*
At a glance
- Drugs RG 7203 (Primary) ; Risperidone
- Indications Schizophrenia
- Focus Adverse reactions; Pharmacokinetics
- 11 Dec 2014 New trial record